Stable efficacy and safety after switching from intravenous to subcutaneous tocilizumab in a cohort of 200 patients in real life conditions.
Larid G, Joffres L, Ricard E, Pereira Gillion C, Herbette M, Lucas C, Cren JB, Bergeal E, Maugars Y, Salliot C, Goupille P, Saraux A, Perdriger A, Bouvard B, Gervais E; Société de Rhumatologie de l’Ouest and the network VICTOR HUGO.
Larid G, et al. Among authors: ricard e.
Joint Bone Spine. 2022 Jul;89(4):105347. doi: 10.1016/j.jbspin.2022.105347. Epub 2022 Jan 20.
Joint Bone Spine. 2022.
PMID: 35066185
No abstract available.